End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
284,500 KRW | -0.52% | +9.63% | +188.83% |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
ETFs positioned on ALTEOGEN Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 2 M€ | -14.14% | ||
0.02% | 4 M€ | -4.41% | - | |
0.01% | 7 M€ | +3.37% | - | |
0.00% | 114 M€ | +6.26% | - | |
0.00% | 36 M€ | +10.98% | - | |
0.00% | 324 M€ | +8.51% | - | |
0.00% | 40 M€ | +7.33% | - | |
0.00% | 32 M€ | +4.15% | - | |
0.00% | 7 M€ | +0.11% | - |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+188.83% | 10.9B | |
+2.99% | 94.76B | |
-3.68% | 37.58B | |
-9.24% | 33.3B | |
+75.54% | 27.92B | |
-13.46% | 15.85B | |
-3.77% | 13.79B | |
-12.31% | 11.51B | |
-53.94% | 9.27B | |
+5.92% | 9.09B |
- Stock Market
- Equities
- A196170 Stock
- Funds and ETFs ALTEOGEN Inc.